Editorial: Precision therapy and biomarkers in head and neck squamous cell carcinoma.

Quiñones, Luis Abel; Han, Fujun; Guo, Ye

Quiñones, Luis Abel; Han, Fujun; Guo, Ye.

Afiliação

Quiñones LA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
Han F; Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.
Guo Y; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF), Santiago, Chile.

Front Oncol ; 14: 1442630, 2024.

Article em En | MEDLINE | ID: mdl-39040458

Palavras-chave

biomarker; epidermal growth factor receptor; head and neck squamous cell carcinoma; immune checkpoint inhibitor; precision therapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Chile País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google